ArticleGenes2025
Cost-Effective Method for Using Cross-Species Spike-In RNA for Normalization and Quantification in Polysome Profiling Experiments.
Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
BACKGROUND/
objectiveAccurate quantification of RNA is critical for RNA-based experiments such as polysome profiling and RT-qPCR. These techniques often rely on control RNA to ensure consistency and reliability across experiments. Commonly used spike-in controls, including in vitro-synthesized mRNA or ERCC mixes, are expensive and time-consuming, limiting accessibility for many laboratories. This study aims to evaluate the use of cross-species total RNA as a cost-effective and reliable spike-in control.
methodsWe developed a method using total RNA from a non-homologous species-specifically, yeast RNA-as a spike-in control for experiments involving human cells. The approach was tested across multiple RNA-based assays to assess its impact on quantification accuracy, reproducibility, and interference with endogenous RNA measurements. Additionally, we applied this method to evaluate the translation efficiency of Bcl-xL mRNA in mammalian cells under hypertonic stress.
resultsCross-species spike-in RNA demonstrated minimal interference with experimental outcomes and provided consistent normalization across replicates. The use of yeast RNA enabled accurate fold-change calculations and improved detection of experimental variability. In the case study involving Bcl-xL mRNA, the spike-in control facilitated reliable assessment of translation efficiency under stress conditions.
conclusionsUsing total RNA from a non-related species as a spike-in control offers a practical, economical alternative to conventional methods. This approach enhances the reliability of RNA quantification without compromising experimental integrity, making it especially valuable for resource-limited settings, particularly in polysome and RT-qPCR workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.